Application of molecular biology to radiobiology and radiation oncology has improved our understanding of cellular radiation responses of both tumor and normal cells and tissues. Consequently, mechanistic insights resulting from molecular radiation biology/oncology research will thus provide tools to develop new strategies of individualized therapy and molecular targeting in modern radiation oncology to further improve tumor responses and reduce normal tissue reactions. Cutting-edge results to these aspects are discussed in the Wolfsberg Meeting Series on Molecular Radiation Biology/Oncology.

Every uneven year, the Wolfsberg Meeting Series, which was started in 1997 and is orga-nized since 2007 in collaboration with ESTRO, the European Society for Radiotherapy & Oncology, brings together both experienced as well as young basic and clinical scientists of the disciplines Molecular and Cell Biology, Tumor and Normal Tissue Biology, Radiobi-ology and Radiation Oncology to discuss the newest developments in these fields of basic and translational research, which most likely will have tremendous impact on the develop-ment of future treatment strategies in radiation oncology.

To promote translation of basic research results into clinical application, the dialogue be-tween basic and clinical scientists needs to be intensified. To achieve this, the structure and spirit of the Wolfsberg Meeting Series create and provide the informal atmosphere which is necessary to discuss specific questions without time pressure usually encoun-tered at bigger conferences. Thus, all basic and clinical researchers and, especially, young scientists are encouraged to discuss newest scientific approaches of importance for trans-lational research in radiation biology/radiation oncology.